DUBLIN--(BUSINESS WIRE)--The "Ocular Hypertension: Drug Development Pipeline Study, H1 2018" report has been added to ResearchAndMarkets.com's offering. Ocular Hypertension report identifies aspects important in modifying industry market scenarios, increasing opportunities and list of potential companies that impact the Ocular Hypertension industry. Ocular Hypertension pipeline comprises of 27 drugs under development as of March 2018. Of these, 2 drugs are in Phase 1 and 13 drugs in phase 2 and

Full Story →

DUBLIN--(BUSINESS WIRE)--The "Ocular Hypertension: Drug Development Pipeline Study, H1 2018" report has been added to ResearchAndMarkets.com's offering. Ocular Hypertension report identifies aspects important in modifying industry market scenarios, increasing opportunities and list of potential companies that impact the Ocular Hypertension industry. Ocular Hypertension pipeline comprises of 27 drugs under development as of March 2018. Of these, 2 drugs are in Phase 1 and 13 drugs in phase 2 and

Full Story →